Zobrazeno 1 - 9
of 9
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The increasing prevalence of depression is a major societal burden. The etiology of depression involves multiple mechanisms. Thus, the outcomes of the currently used treatment for depression are suboptimal. The anti-depression effects of traditional
Externí odkaz:
https://doaj.org/article/73b5a056e8a34bbca159849f818fb6fc
Autor:
Guangheng Zhang, Shimeng Lv, Xia Zhong, Xiangyu Li, Yunhao Yi, Yitong Lu, Wei Yan, Jiamin Li, Jing Teng
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
The incidence rate of depression, a mental disorder, is steadily increasing and has the potential to become a major global disability factor. Given the complex pathological mechanisms involved in depression, the use of conventional antidepressants ma
Externí odkaz:
https://doaj.org/article/0fe36d4d36bf47c8bbb0fff8e99e7e85
Autor:
Shimeng Lv, Guangheng Zhang, Yufei Huang, Xia Zhong, Yunhao Yi, Yitong Lu, Jiamin Li, Yuexiang Ma, Jing Teng
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Depression is characterized by prominent indicators and manifestations, such as anhedonia, which refers to the inability to experience pleasure, and persistent feelings of hopelessness. In clinical practice, the primary treatment approach involves th
Externí odkaz:
https://doaj.org/article/faa8c43f0d2f4948ad5ef11256f847ba
Autor:
Shimeng Lv, Guangheng Zhang, Yufei Huang, Jiamin Li, Ni Yang, Yitong Lu, Haoteng Ma, Yuexiang Ma, Jing Teng
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The core symptoms of depression are anhedonia and persistent hopelessness. Selective serotonin reuptake inhibitors (SSRIs) and their related medications are commonly used for clinical treatment, despite their significant adverse effects. Traditional
Externí odkaz:
https://doaj.org/article/388fcd7971794007a9fd02e8f264443d
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Depression is one of the common complications in patients with postoperative breast cancer (BC). Conventional therapies for postoperative depression of BC always have modest treatment outcomes and undesirable side effects. Clinical practi
Externí odkaz:
https://doaj.org/article/e49e28197cea4a2aa1c0595a001f2638
Autor:
Yi Zhang, Xiaoman Xu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Depression is one of the most common non-motor symptoms in patients with Parkinson’s disease (PD). Depression in PD (DPD) increases the disability rate and reduces the quality of life of PD patients and increases the caregiver burden. Although prev
Externí odkaz:
https://doaj.org/article/31a0a93acf5248ef887ca15b1cfa7c84
Autor:
Xiaofei Zhu, Teng Li, En Hu, Lihua Duan, Chunhu Zhang, Yang Wang, Tao Tang, Zhaoyu Yang, Rong Fan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Background: Chaihu-Shugan-San is a classical prescription to treat depression. According to the traditional Chinese medicine (TCM) principle, the 2 decomposed recipes in Chaihu-Shugan-San exert synergistic effects, including Shu Gan (stagnated Gan-Qi
Externí odkaz:
https://doaj.org/article/392d707de8974bfbba67a6a3e2e7c82a
Autor:
Lei Gao, Peng Huang, Zhaoyang Dong, Tingting Gao, Shaohui Huang, Chuying Zhou, Yuling Lai, Guanghui Deng, Bin Liu, Ge Wen, Zhiping Lv
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/083838acc1544fe58ef521d8f759918d
Autor:
Lei Gao, Peng Huang, Zhaoyang Dong, Tingting Gao, Shaohui Huang, Chuying Zhou, Yuling Lai, Guanghui Deng, Bin Liu, Ge Wen, Zhiping Lv
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
As the traditional Chinese herbal formula, Xiaoyaosan and its modified formula have been described in many previous studies with definite anti-depressive effects, but its underlying mechanism remains mystery. Previous work in our lab has demonstrated
Externí odkaz:
https://doaj.org/article/7f51a2942c6842ccbf1279c9cb5df27a